-
Loading metrics
DW-MRI as a Biomarker to Compare Therapeutic Outcomes in Radiotherapy Regimens Incorporating Temozolomide or Gemcitabine in Glioblastoma
- Stefanie Galbán,
- Benjamin Lemasson,
- Terence M. Williams,
- Fei Li,
- Kevin A. Heist,
- Timothy D. Johnson,
- Judith S. Leopold,
- Thomas L. Chenevert,
- Theodore S. Lawrence,
- Alnawaz Rehemtulla
x
- Published: April 20, 2012
- https://doi.org/10.1371/journal.pone.0035857